Bennett, Jason W <br/><br/>
Phase 1/2a Trial of Plasmodium vivax Malaria Vaccine Candidate VMP001/AS01B in Malaria-Naive Adults: Safety, Immunogenicity, and Efficacy.  [electronic resource] 

 -  PLoS neglected tropical diseases  Feb 2016 
 - e0004423 p.  digital 
<br/><br/> Publication Type: Clinical Trial, Phase I; Clinical Trial, Phase II; Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S. 
<br/><br/><label>ISSN: </label>1935-2735 
<br/><br/><label>Standard No.: </label>10.1371/journal.pntd.0004423  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adolescent<br/>Adult<br/>Antibodies, Protozoan--immunology<br/>Female<br/>Humans<br/>Malaria Vaccines--administration & dosage<br/>Malaria, Vivax--immunology<br/>Male<br/>Middle Aged<br/>Plasmodium vivax--immunology<br/>Protozoan Proteins--administration & dosage<br/>Vaccination<br/>Young Adult